Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Bicycle Therapeutics

04/11/2021 18:13

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted loss of 59 cents​​ per share for the quarter ended in
September. The mean expectation of ten analysts for the quarter
was for a loss of 61 cents per share.
* Revenue rose 12.8% to $4.33 million from a year ago;  analysts
expected $4.43 million. 
* Bicycle Therapeutics PLC's reported EPS for the quarter was a
loss of 59 cents​.
* The mean earnings estimate of analysts had fallen by
about 36.2% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Bicycle Therapeutics PLC shares had risen by 35.9% this
quarter and gained 214.9% so far this year.
* The company reported a quarterly loss of $14.68 million.
* Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $68.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 4 at 06:13 p.m.
 ​All figures in US dollars unless otherwise stated